Va Tech Wabag Ltd. 11 th March, 2014 BUY

Transcription

1 Company Report BROKING DEPOSITORY DISTRIBUTION FINANCIAL ADVISORY Va Tech Wabag Ltd. 11 th March, 2014 BUY CMP Target Price Rs Rs VA Tech Wabag is Indian multinational player technology focused company which provides a complete range of water and waste water treatment solutions. BSE Code NSE Code WABAG Market Cap (Rs Cr.) Week High/Low / Industry Capital Goods Face Value Rs.2.00 Shares O/S 2.66 Cr. The company has registered robust results for the quarter ending December The consolidated revenue has increased by about 66% at Rs crore for quarter under review as compared to Rs.354 crore for the quarter ended December 31, The company s business managed and operated out of India has contributed to the stellar performance. Operating profit climbed sharply by ~84% at about Rs crores as against Rs crores in the previous year quarter. The net profit of the company skyrocketed by about 116% at Rs crores as compared to Rs crore for the same quarter in the previous year. The company s Multi Domestic Unit strategy is paying off well. EPS(TTM) Book Value P/E P/B 2.30 Shareholding Pattern Revenue from international business for the quarter is at Rs crore against Rs crore, a rise of % y-o-y. Domestic revenue for the quarter stood at Rs crore against Rs crore, a jump of 35.54% y-o-y. Order inflow for 9MFY14 stood at Rs crores comprising domestic orders worth Rs.1844 cr and Rs cr overseas. The inflow includes EPC orders worth Rs cr comprising 86% of the order inflow while O&M orders stood at Rs cr representing the remaining 14%. Municipal order inflow was at Rs.2233 cr while Industrial orders were at Rs cr. Valuation Research Analyst: Vineeta Mahnot vineeta@hemonline.com With asset light model, robust order pipeline, strong balance sheet, leadership position in Indian market and increasing geographical presence with strong brand image; Va Tech Wabag Ltd. revenue visibility looks strong. We believe the company is trading at an attractive valuation at 16.86x and 14.24x of FY14EPS of Rs and FY15EPS of Rs We initiate a BUY on the stock with a target price of Rs.870 (appreciation of about 26%) with the medium to long term investment horizon. For Private Circulation Only 1 Hem Research

2 Business Details WABAG is one of the world s leading companies in the water treatment field. The company is a multinational player in the water treatment industry with market presence in India, the Middle East, North Africa, Central and Eastern Europe, China and South East Asia through principal offices in India, Austria, the Czech Republic, China, Switzerland, Algeria, Romania, Tunisia, UAE, Libya and Macao. The company is headquartered in Chennai and conducts global operations through its 17 Subsidiaries and branch and representative offices. They share strategic and technical expertise across the Subsidiaries that believe, allow research, operational and marketing synergies. VA Tech offers complete life cycle solutions including conceptualization, design, engineering, procurement, supply, installation, construction and O&M services. They provide a range of EPC and O&M solutions for sewage treatment, processed and drinking water treatment, effluents treatment, sludge treatment, desalination and reuse for institutional clients like municipal corporations and companies in the infrastructure sector such as power, steel and oil and gas companies. The company has turnkey contracts which involve design, engineering, procurement, construction, erection, commissioning, operation and maintenance of the following: Drinking water treatment Industrial waste water treatment Municipal waste water treatment Industrial and process water treatment Desalination (sea water and brackish water) Recycling (industrial and municipal waste water) WABAG offers sustained solutions for special customer needs through a comprehensive range of services and innovative technologies. Its plants facilitate environmentally compatible wastewater disposal and secure access to clean drinking water for an increasing number of people. This allows it to make an important contribution to environmental protection and enhanced quality of life. For Private Circulation Only 2 Hem Research

3 Robust Order Book The Company has registered strong order inflow for the quarter ended December 2013 which stood at Rs crores and for the nine months ended December 2013 stood at Rs crores with major order inflow from overseas business even in turbulent times. This nine-month order intake in FY14 has surpassed full year order intake for last three financial years despite of global economic slowdown and policy paralysis in India. Order book stood at Rs.6000 crores as on Dec This firm order book has strong visibility and sustainability. The company has strong execution track record of more than 2250 projects in last 3 decades. The company has Rs.398 crores inflow of framework contracts in nine months ended December 2014; out of which Rs.244 crores moved to firm order book in January There has been a tremendous increase of in average order size from Rs.136 crores in FY13 to Rs.183 crores in 9MFY14. The company expects healthy order inflows to continue in FY15 on back of orders in pipeline. For Private Circulation Only 3 Hem Research

4 Increasing geographical presence The Company has plans to diversify in high potential growing economies with utilization of low cost Indian resources. The company is leveraging Indian resources for gaining momentum in international geographies. Well diversified geographical presence has reduced dependence on single country. Decentralized operations have helped improving client satisfaction and EBIDTA margins. Cost of operations also has improved in international business on account of such decentralization. The company has educes expenses in high cost geographies and invested in high potential water markets by establishing local presence (MDUs). For Private Circulation Only 4 Hem Research

5 Upped Guidance The Company has given a guidance to achieve revenue between Rs crores in financial year ending March 2013; which it has achieved already. Similarly the order intake for FY13 was projected between Rs.2,000-Rs.2,100 crores which was clocked and met the guidance during the respective year. VA Tech has upped its revenue guidance for FY14 from Rs crores to Rs.2000 crores. The order intake guidance for FY14 was previously projected at Rs crores which has been easily surpassed in nine months ended December Therefore, the company has upped its order inflow guidance at Rs.3500 crores for FY14. Going forward, the company aims at improving its margins in International Business. With the backlog of robust order book backed by funded projects along with its strong inherent execution capability; the company expects to have strong FY14. For Private Circulation Only 5 Hem Research

6 Consolidated Profit & Loss Account Rs. Crore Particulars FY11 FY12 FY13 FY14E FY15E Net sales Growth 16.24% 12.15% 23.00% 16.50% Expenditure EBITDA Growth 7.44% 19.10% 24.71% 17.70% EBITDA margin 9.75% 9.01% 9.57% 9.70% 9.80% Other income Depreciation & Amortisation EBIT EBIT margin 8.94% 9.46% 9.71% 9.55% 9.62% Interest PBT Tax PAT Minority interest Share of profits in Associates Adjusted PAT Growth Net Profit margins Exceptional item Reported PAT Equity Capital Equity Shares Adjusted EPS Ratios Particulars FY11 FY12 FY13 FY14E FY15E Return on Equity Return on Capital employed Debt/Equity Asset turnover Current Ratio For Private Circulation Only 6 Hem Research

7 Balance Sheet Rs. Crore Particulars FY11 FY12 FY13 FY14E FY15E Share Capital Reserves & Surplus Shareholders funds Borrowings Deferred tax liability Minority Interest Sources of funds Gross block Accumulated Depreciation Net block Capital work in progress Investments Deferred tax assets Goodwill on consolidation Inventories Sundry debtors , , , , Cash and bank balance Other current assets Loans and advances Total current assets 1, , , , , Current liabilities and provisions , , , , Net current assets Misc exp Uses of funds , For Private Circulation Only 7 Hem Research

8 Quarterly Financial Highlights Rs. Crore Particulars Q3FY14 Q3FY13 Q2FY14 YoY% QoQ% Revenues Expenditures Operating Profit Adjusted Net Profit OPM% bps 12bps NPM % bps (6bps) Adjusted EPS Past Price movement of the stock 770 VA TECH WABAG ( , , , , ) rch April May June July August September October November December 2014 February March For Private Circulation Only 8 Hem Research

9 HEM SECURITIES LIMITED MEMBER-BSE,CDSL, SEBI REGISTERED CATEGORY I MERCHANT BANKER MUMBAI OFFICE: 14/15, KHATAU BLDG., IST FLOOR, 40, BANK STREET, FORT, MUMBAI PHONE FAX JAIPUR OFFICE: , JAIPUR TOWERS, M I ROAD, JAIPUR PHONE FAX GROUP COMPANIES HEM FINLEASE PRIVATE LIMITED MEMBER-NSE HEM MULTI COMMODITIES PRIVATE LIMITED MEMBER-NCDEX, MCX HEM FINANCIAL SERVICES LIMITED NBFC REGISTERED WITH RBI For Private Circulation Only 9 Hem Research

10 Disclaimer & Disclosure: This document is prepared for our clients only, on the basis of publicly available information and other sources believed to be reliable. Whilst we are not soliciting any action based on this information, all care has been taken to ensure that the facts are accurate, fair and reasonable. This information is not intended as an offer or solicitation for the purchase or sell of any financial instrument and at any point should not be considered as an investment advise. Reader is requested to rely on his own decision and may take independent professional advise before investing. Hem Securities Limited, Hem Finlease Private Limited, Hem Multi Commodities Pvt. Limited, Directors and any of its employees shall not be responsible for the content. The person accessing this information specifically agrees to exempt Hem Securities Limited, Hem Finlease Private Limited, Hem Multi Commodities Pvt. Limited or any of its affiliates or employees from, any and all responsibility/liability arising from such misuse and further agrees to hold Hem Securities Limited, Hem Finlease Private Limited, Hem Multi Commodities Pvt. Limited or any of its affiliates or employees free and harmless from all losses, costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays. The companies and its affiliates, officers, directors, and employees, including persons involved in the preparation or issuance of this material may from time to time, have long or short positions in, and buy or sell the securities there of, company (ies) mentioned here in and the same have acted upon or used the information prior to, or immediately following the publication. Disclosure of Interest Statement Company Name 1. Analyst Ownership of the Stock No 2. Hem & its Group Company Ownership of the Stock Yes 3. Hem & its Group Companies Director Ownership of the Stock Yes 4. Broking relationship with company covered No Analyst Certification The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly related to the specific recommendations and views expressed by research analyst(s) in this report. For Private Circulation Only 10 Hem Research